Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks

Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks

BackgroundThis study examines the risks of hypertension and thrombotic events in NSCLC patients treated with Tyrosine Kinase Inhibitors (TKIs).ObjectiveTo compare the safety profiles of TKIs used in NSCLC treatment, focusing on hypertension and thrombotic risks.MethodsA comprehensive search identifi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingming Tan, Chenwei Pu, Zhenzhen Wang, Chengwei Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
non-small cell lung cancer
tyrosine kinase inhibitors
hypertension
thrombotic events
network meta-analysis
NSCLC
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1491990/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items